Last updated: 2026-11-14 09:12:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Rezolute, Inc. (RZLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.65, with a market capitalization of $374.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $11.17. This page covers its latest market performance, valuation, price trends and company information.
$374.34M | |
$4.56 | |
$4.61 | |
$3.61 | |
$3.87 | |
5.53M | |
1.61M | |
-- | |
$11.17 | |
$1.07 | |
-- | |
-- |
Rezolute, Inc. (RZLT) last closed at $3.65 as of 2026-11-14 00:50:00, down 5.68% ($0.22) from the previous close of $3.87.
During the latest regular trading session, RZLT traded between $3.61 and $4.61, with a volume of 5.53M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Rezolute, Inc. (RZLT) moved from $3.64 to $3.65, representing a gain of 0.19% ($0.01).
The stock traded between $3.56 and $4.61 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 2.09 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 25.5%
RZLT is currently trading at $3.65, placing it 25.5% of the way from its 52-week low of $1.07 to its 52-week high of $11.17. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Rezolute, Inc. and RZLT stock.
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report
Underwritten offering of 22,040,976 shares of its common stock at an offering price of $3.87 per share, and to certain investors in lieu of common stock, pre-funded warrants to purchase up to 3,800,000 shares of common
The primary efficacy endpoint in the upLIFT study is the proportion of patients able to achieve at least a 50% reduction from baseline in glucose infusion rate (GIR), a measure of intravenous glucose dependency for
Eligible investors can buy real shares of Rezolute, Inc. (RZLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RZLT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between RZLT shares and USD.
RZLT Shares to USD
1.00 RZLT shares = 3.647 USD
Calculations are estimates based on the latest available price and are for reference only.
